Long-Term Safety and Effectiveness of Adalimumab for Moderate to Severe Psoriasis: Results from 7-Year Interim Analysis of the ESPRIT Registry

Por Menter, Alan, Thaçi, Diamant, Wu, Jashin J., Abramovits, William, Kerdel, Francisco, Arikan, Dilek, Guo, Dianlin, Ganguli, Arijit, Bereswill, Mareike, Camez, Anne, Valdecantos, Wendell C.
Publicado no Dermatol Ther (Heidelb) (2017)

Efficacy and safety of adalimumab in Japanese patients with moderately to severely active ulcerative colitis

Por Suzuki, Yasuo, Motoya, Satoshi, Hanai, Hiroyuki, Matsumoto, Takayuki, Hibi, Toshifumi, Robinson, Anne M., Mostafa, Nael M., Chao, Jingdong, Arora, Vipin, Camez, Anne, Thakkar, Roopal B., Watanabe, Mamoru
Publicado em 2013